Cannabis Law Report

SEPTEMBER 8, 2021

The mission of the United Cannabis Business Association is to establish a comprehensive, statewide cannabinoid policy. Responsible policy prioritizes public health and safety and promotes the viability of both California’s legal cannabis industry and the legal hemp industry. .

Cannabinoids 95

Cannabinoids Policy Advocacy Hemp 95

MMJ Recs

NOVEMBER 20, 2023

This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). This, the authors say, “is well below the dose commonly associated with pharmaceutical products (e.g. CBD, which constitutes a $2,770.8

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

AUGUST 23, 2021

Oxford Cannabinoid Technologies Holdings plc. Pre-Close Trading Update; US OTC QB Market Application. & & Notice of 2021 Final Results. . Details of a presentation to investors via the InvestorMeet Platform will be announced shortly. Since the year-end, the £2.6

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

Cannabis Law Report

JULY 28, 2021

On 1 June 2021, the Group announced an agreement with Voisin Consulting SARL (“VC”), a life sciences consultancy comprising over 200 professionals in the UK, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addictions.

Cannabinoids 81

Cannabinoids Clinical Trials Safety Medicine 81

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. SciSparc intends to evaluate the efficacy, safety and tolerability of its SCI-110 in a randomized, double-blind, placebo controlled, cross-over study. About SciSparc (OTCQB: SPRCY): SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. There are some minimum and maximum cannabinoid contents with the program. ” We later lowered the minimum cannabinoid requirement. ” “5 percent” translates into 50mg/mL.

Marijuana 247

Marijuana Legalization Programs Oil 247

Cannabis Law Report

JUNE 17, 2021

This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry,” said Brains’ CEO & Chairman Rick Brar.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

The Cannigma

FEBRUARY 16, 2021

They require a process in which THC or other cannabinoid particles are reduced to nanoscopic size that allows them to then be mixed with water or other aqueous liquids. There is not extensive safety data available, however. The nanoemulsion method ALT uses is effective for all cannabinoids, not only THC, he said. Shutterstock).

Edibles 138

Edibles Digestion Tincture Cannabinoids 138

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Common cannabinoids in cannabis.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Canna Law Blog

FEBRUARY 21, 2020

Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. The EFSA guidance on cannabinoids strongly echoes the U.S. The EFSA guidance on cannabinoids strongly echoes the U.S.

Food 117

Food CBD Legalization Hemp 117

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Although CBD’s full medical benefits and safety profile are still under review by researchers and appropriate regulators, the compound has successfully scaled several legal roadblocks.

CBD 96

CBD Cannabinoids THC Extraction 96

MMJ Recs

JUNE 30, 2024

Ensuring the potency and safety of cannabis edibles and oils is paramount for patients reliant on their therapeutic benefits. Patients can choose from a range of flavors and cannabinoid ratios to tailor their experience to their specific needs. Image by Elsa Olofsson on Unsplash.

Edibles 111

Edibles Oil Packaging Patients 111

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Healthcare Communications.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” She ends the column by stating “ I urge our legislators to abandon this legislation for the sake of our citizen’s health and safety.”.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

PrestoDoctor

DECEMBER 12, 2023

Cannabis contains compounds called cannabinoids, such as THC and CBD. These cannabinoids interact with the body’s endocannabinoid system to produce various therapeutic effects. Many pharmaceutical drugs come with side effects and the risk of dependency. Cannabis contains cannabinoids like THC and CBD.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

Cannabis Law Report

JUNE 20, 2021

According to the World Health Organization, the toxicity of THC is “very low” compared to most other recreational and pharmaceutical drugs. CBD food products must be authorized by the Commission and undergo a pre-market safety assessment by the European Food Safety Authority (EFSA) before they can be legally marketed in the EU.

THC 81

THC CBD Food Safety 81

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

MARCH 17, 2021

Some women who chose to use cannabis for postpartum depression say they did so because standard prescription treatments did not help and the side effects from pharmaceutical treatments were intolerable. Of course, if a new mother is not breastfeeding, this is a moot point.

Research and Development 143

Research and Development Treatment Sleep Cannabis 143

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety. About IGC: India Globalization Capital, Inc.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

CannaMD

MAY 14, 2020

These figures do not include homemade edibles made from cannabinoid-infused oils, so the actual percentage of use may be higher!). Safety of production and packaging. When raw cannabis is subjected to heat, non-psychoactive cannabinoids such as THC-A and CBD-A are converted to THC and CBD through a process known as decarboxylation.

Edibles 105

Edibles Marijuana THC Vaping 105

Cannabis Law Report

MARCH 26, 2022

The Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI), and First November Group, recently announced the launch of a new wide-ranging commission to review regulation and public policy in the United Kingdom’s (UK) legal cannabis industry called the Hodges Review.

Cannabinoids 52

Cannabinoids Research and Development Supply Chain Policy 52

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. Approved cannabinoids for medical purposes: Comparative systematic review and meta-analysis for sleep and appetite. phosphorus, potassium, and calcium). 2 The seeds of C. PubMed search: “CBD review.”

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 11, 2023

PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.

Clinical Trials 52

Clinical Trials CBD Sleep Pharmaceutical 52

MedicalJane

MAY 21, 2020

Researchers at The University of New Mexico (UNM) have conducted a series of recent studies testing the effectiveness and safety of consuming cannabis, but this is the first study they have conducted measuring the therapeutic potential of hemp oil with low THC levels. Hemp” is defined in the Act as “the plant Cannabis sativa L.

Oil 100

Oil Hemp Extraction Clinical Trials 100

Cannabis Law Report

MAY 8, 2022

I have an extensive background in healthcare and have worked in the community, aged care and palliative care sectors as well the corporate (pharmaceutical and insurance) sectors. Road Safety laws to be amended to allow for a defence for medicinal users. Click on image to watch on you tube.

Education 98

Education Medicine Cannabinoids Programs 98

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. What Does Epidiolex Treat?

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

OCTOBER 22, 2021

Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. Lenabasum is a novel, oral, small molecule that selectively binds as an agonist to the cannabinoid receptor type 2 (CB2) and resolves inflammation and limits fibrosis in animal and human models of disease.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

JUNE 15, 2021

This landmark investment and strategic transaction solidifies Brains’ position as one of the leading pharmaceutical companies in the cannabinoid (CBD) sector. To have the confidence of DSM in this next round solidifies Brains strategic position within the pharmaceutical industry,” said Brains’ CEO & Chairman Rick Brar.

Pharmaceutical 63

Pharmaceutical Clinical Trials Research and Development Events 63

Miss Marijuana

NOVEMBER 4, 2020

As a company that takes pride in their safety level, Matter produces quality, effective, and consistent products that can provide therapeutic relief to those suffering from chronic medical conditions. The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. Abx – AbsoluteXrracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Cannabis Law Report

JANUARY 10, 2020

Being a member of the Drug Science Medical Cannabis Working Group, Schlag’s current research focuses on the controversies surrounding medical cannabis and the application of MultiCriteria-Decision-Analysis to assess benefits and safety. Deepak Anand. Deepak Anand is recognised as a thought leader in the global cannabis space.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

MARCH 6, 2020

” In 2018, Europe was responsible for 23.2% of the world’s pharmaceutical sales with the size of the market in the EU-5 ( United Kingdom , Germany , Spain , France , and Italy ) set to grow by 25% between 2017 and 2022. It’s safety and efficacy have not been confirmed by FDA-approved research.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

JANUARY 16, 2020

Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

Extraction 49

Extraction Pharmaceutical Research and Development Terpenes 49

Cannabis Law Report

AUGUST 23, 2021

Abernethy said, “We [FDA] remain focused on exploring potential pathways for CBD products to be lawfully marketed while also educating the public about these outstanding questions of CBD’s safety.”. How are CBD and other hemp-containing pet products being marketed today?

Pets 105

Pets Hemp CBD Food 105